Baird Financial Group, Inc. Myriad Genetics Inc Transaction History

Baird Financial Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$16.45 - $25.88 $6,481 - $10,196	394 Added 2.58%	15,662 $285,000
Q1 2022 May 13, 2022	BUY	$22.67 - $28.01 $21,695 - $26,805	957 Added 6.69%	15,268 $384,000
Q4 2021 Feb 09, 2022	SELL	$24.13 - $32.63 $723 - $978	-30 Reduced 0.21%	14,311 $395,000
Q3 2021 Nov 12, 2021	BUY	$29.97 - $36.66 $429,799 - $525,741	14,341 New	14,341 $463,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.